Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 15.12.2023AstraZeneca AB (AZC)6372BFluenz Tetra nosová suspenzná aerodisperzia (aer nau 10x0,2 ml (aplik.nos.jedn.skl.))15.12.2023O
 15.12.2023UCB Pharma S.A. (UCP)0111AVimpat 10 mg/ ml infúzny roztok (sol inf 5x20 ml (liek.skl.))16.2.2024Z
 15.12.2023UCB Pharma S.A. (UCP)0112AVimpat 10 mg/ml sirup (sir 1x200 ml (fľ.skl.))16.2.2024Z
 15.12.2023UCB Pharma S.A. (UCP)52856Vimpat 50 mg filmom obalené tablety (tbl flm 56x50 mg (blis.PVC/PVDC/Al))16.2.2024Z
 15.12.2023UCB Pharma S.A. (UCP)52859Vimpat 100 mg filmom obalené tablety (tbl flm 56x100 mg (blis.PVC/PVDC/Al))16.2.2024Z
 15.12.2023UCB Pharma S.A. (UCP)52862Vimpat 150 mg filmom obalené tablety (tbl flm 56x150 mg (blis.PVC/PVDC/Al))16.2.2024Z
 15.12.2023UCB Pharma S.A. (UCP)52865Vimpat 200 mg filmom obalené tablety (tbl flm 56x200 mg (blis.PVC/PVDC/Al))16.2.2024Z
 15.12.2023G.L. Pharma GmbH (GLH-2)6476BAricogan 10 mg tablety (tbl 30x10 mg (blis.OPA/Al/PVC/Al))14.12.2023Z
 15.12.2023MEDOCHEMIE Ltd. (MOE)15573COSTI (tbl 30x10 mg (blis.))13.12.2023R
 15.12.2023MEDOCHEMIE Ltd. (MOE)39274MEDORISPER 2 mg (tbl flm 50x2 mg (blis.PVC/PE/PVDC/Al))13.12.2023R
 15.12.2023MEDOCHEMIE Ltd. (MOE)46311RAMIMED HCT 5/25 (tbl 30x5 mg/25 mg (blis.OPA/Al/PVC/Al))13.12.2023R
 15.12.2023MEDOCHEMIE Ltd. (MOE)5231BAXETINE 250 mg (tbl flm 10x250 mg (blis.Al/Al))13.12.2023R
 15.12.2023MEDOCHEMIE Ltd. (MOE)59193BETAC (tbl flm 100x20 mg (blister PVC/Al))13.12.2023R
 15.12.2023MEDOCHEMIE Ltd. (MOE)67015GYRABLOCK 400 mg (tbl flm 14x400 mg (fľ.PE))13.12.2023R
 15.12.2023MEDOCHEMIE Ltd. (MOE)67570MABRON 50 mg (cps dur 30x50 mg (blis.Al/PVC))13.12.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)